Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler’s Diarrhea in Children Age 12 to 17 Years
Condition(s):Traveler’s DiarrheaLast Updated:January 27, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Traveler’s DiarrheaLast Updated:January 27, 2023Not yet recruiting
Condition(s):Traveler’s DiarrheaLast Updated:January 27, 2023Not yet recruiting
Condition(s):PulmonologyLast Updated:October 20, 2022Recruiting
Condition(s):Hepatic Encephalopathy; Cirrhosis, LiverLast Updated:September 21, 2023Completed
Condition(s):Small Intestinal Bacterial Overgrowth; Gastrointestinal Disease; Gastrointestinal InfectionLast Updated:May 5, 2022Enrolling by invitation
Condition(s):Traveler’s DiarrheaLast Updated:June 8, 2018Completed
Condition(s):Uncomplicated DiverticulitisLast Updated:July 26, 2017Completed
Condition(s):Traveler’s DiarrheaLast Updated:February 27, 2019Completed
Condition(s):Impacted Third Molar ToothLast Updated:August 22, 2023Active, not recruiting
Condition(s):HealthyLast Updated:January 26, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.